Wyomissing Optometric Center — Wyomissing, Pennsylvania

Wyomissing Optometric Center is a clinical research site located in Wyomissing, Pennsylvania, United States 19610.

Crixeo Clinical Trials Trust Score: 16/100 (FAILING). This profile has not yet been claimed by the site owner.

Wyomissing Optometric Center has participated in 7 clinical trials.

Therapeutic areas: Refractive Errors, Myopia, Refractive Ametropia.

Sponsors: Alcon Research, Shire.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Wyomissing

Browse all research sites in Pennsylvania · View every site in Wyomissing

• reading Hospital /ID# 223599
• Reading Hospital Study
• Reading Hospital/McGlinn Cancer Institute
• Clinical Research Center of Reading
• Research Site
• GSK Investigational Site
• Pfizer Investigational Site
• Berks Cardiologists, LTD
• Radiant Research
• Respiratory Specialists
• Clinical Research Center of Reading LLP
• Digestive Disease Associates

Sponsor Feasibility Report

Trust Score: 16/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Wyomissing Optometric Center?

Wyomissing Optometric Center has a Crixeo Trust Score of 16/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Wyomissing Optometric Center conducted?

Wyomissing Optometric Center has 7 clinical trials on record. Their work covers Refractive Errors, Myopia, Refractive Ametropia.

Is Wyomissing Optometric Center accredited by Crixeo Clinical Trials?

Wyomissing Optometric Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Wyomissing Optometric Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.